Mar 1, 2023
La Jolla Labs Lights Up for Rare in Global Chain of Lights on Rare Disease Day
La Jolla Labs participates in the Global Chain of Lights to show support and raise awareness for rare diseases and patients on Rare Disease Day.
Feb 28, 2023
How Artificial Intelligence Will Drive Rare Disease Therapeutics Jeff Milton CEO - La Jolla Labs
Tune in to hear Founder and CEO of La Jolla Labs, Jeff Milton, explain how new artificial intelligence will drive rare disease therapeutics at iXCells Biotechnologies' Rare Disease Day Webinar.
Jan 30, 2023
Jeff Milton, CEO at La Jolla Labs Inc., presented at the N=1 Collaborative Seminar Series: “A Model for Sustainable Discovery in Rare Disease”
Millions of patients world-wide suffer from rare disease and while non-profit organizations provide a platform for certain indications, only a few have succeeded in delivering meaningful therapeutics to patients. To address rare disease in a comprehensive and sustainable manner requires a fundamental change to drug discovery; a change that opens a competitive landscape with risks and rewards that match those found in big pharma. I will present a model that leverages modern technology and the interconnected nature of disease to provide “economic runways” for many rare disease programs.
Dec 20, 2022
They Created a Drug for Susannah. What About Millions of Other Patients?
Today, we have the science to help dying children, but little to no access because our system wasn't designed for medicines for one or very few people. The drug development process may work for large diseases, but to help those with rare diseases, we must now pivot and build a parallel system for individualized medicines.
Oct 21, 2022
Revealing Rare Genes Blog Release
Revealing Rare Genes is a blog covering topics at the intersection of rare diseases and RNA therapeutics. We feature individual diseases, highlight patient stories, and delve into the challenges of bringing these therapies to market. Sometimes science can feel disconnected from the real world and everyday people. Through this blog we aim to forge connections that drive drug development for rare diseases forward: to connect all people with stories to inspire action; scientists with research challenges to overcome; and clinicians with healthcare gaps to address.
Mar 16, 2022
La Jolla Labs and n-Lorem Foundation Partner to Discover Personalized ASO Medicines for Nano-rare Patients
Partnership leverages La Jolla Labs’ automated, high-throughput screening technology to identify optimal ASO candidates.